LLY-283
LLY-283 is a potent, selective, and orally bioavailable inhibitor of the PRMT5:MEP50 complex, demonstrating high affinity with a Kd of 6 nM. It exhibits robust antitumor activity and is a valuable chemical probe for investigating PRMT5 biology in cancer research, both in cellular and animal models.
Product Specifications
CAS Number
2040291-27-6
Product Name Alternative
Histone Methyltransferase, HistoneMethyltransferase, MEP50, LLY283, LLY-283, LLY 283, PRMT5
Field of Research
Epigenetics & Chromatin
Purity
98.79% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (11.68 mM) ; H2O:3.57 mg/mL (10.43 mM) ; DMSO:112.5 mg/mL (328.61 mM)
Smiles
[H][C@@]1 (O[C@H] ([C@H] (O) [C@@H]1O) n1ccc2c (N) ncnc12) [C@H] (O) c1ccccc1
Molecular Formula
C17H18N4O4
Molecular Weight
342.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15167105 1 Vial
Lentiviral mouse Rbbp8nl shRNA (UAS) - Lentiviral mouse Rbbp8nl shRNA (UAS) (25)
Sign In for Pricing
View Details 